Use of Maraviroc (MVC) in Immunological Non-Responder HIV-1-Infected Patients.
Phase of Trial: Phase IV
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Maraviroc (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
- 15 Oct 2011 Results presented at the 13th European AIDS Conference.